Abbott India Limited (ABBOTINDIA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE358A01014
Key metrics
- Market Cap
- ₹55,779 Cr
- P/E Ratio
- 34.51
- EPS
- 760.67
- Book Value
- 2,246.75
- P/B Ratio
- 11.63
- ROE
- 32.51%
- ROCE
- 36.89%
- Debt / Equity
- 0.04
- Net Margin
- 22.41%
- Revenue Growth
- 8.12%
- Profit Growth
- 9.73%
- Dividend Yield
- 2%
- 52W High
- ₹32,775.00
- 52W Low
- ₹25,150.00
- Market Cap Band
- large cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
- Headquarters
- Mumbai, India
- Employees
- 3,679
- Promoter Holding
- 75.54%
The full Abbott India Limited analysis
Create a free account to open the complete ABBOTINDIA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.